The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Gall Matthew since 2021.
This trader's CIK number is 1816194.
At the time of last reporting, Gall Matthew was the Chief Financial Officer of Iteos Therapeutics, Inc.. (stock ticker symbol ITOS).
Also see all insider trading activities at Iteos Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | ITOS | 5,000 | $38,635 | 0 | $0 | 0 | $0 |
| 2023 | ITOS | 5,000 | $41,849 | 0 | $0 | 0 | $0 |
| 2021 | ITOS | 5,000 | $130,445 | 5,000 | $232,250 | 14,429 | $88,882 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-11-19 | ITOS | Buy | 5,000 | 7.73 | 38,635 |
| 2023-10-12 | ITOS | Buy | 5,000 | 8.37 | 41,849 |
| 2021-12-27 | ITOS | Sale | 5,000 | 46.45 | 232,250 |
| 2021-10-11 | ITOS | Option Ex | 14,429 | 6.16 | 88,882 |
| 2021-06-16 | ITOS | Buy | 5,000 | 26.09 | 130,445 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Gall Matthew (Chief Financial Officer of Iteos Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.